These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 541004)

  • 1. Haematological investigations in kala-azar patients in Bihar.
    Aikat BK; Mohanty D; Pathania AG; Bhattacharya PK; Jain S; Chari NC; Kumar S; Sahaya S; Prasad LS
    Indian J Med Res; 1979 Oct; 70():571-82. PubMed ID: 541004
    [No Abstract]   [Full Text] [Related]  

  • 2. ABO blood group distribution in kala-azar in Bihar, India.
    Lal S; Ranjan A; Nandkumar ; Kar SK; Prabhakar R
    J Assoc Physicians India; 1995 Apr; 43(4):300. PubMed ID: 8713279
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of a haemolytic component and the type of hypochromic microcytic anaemia in kala-azar.
    Aksoy M; Akgün T; Erdem S; Dinçol K
    Z Tropenmed Parasitol; 1970 Jun; 21(2):154-9. PubMed ID: 5428245
    [No Abstract]   [Full Text] [Related]  

  • 5. A new strategy for elimination of kala-azar from rural Bihar.
    Thakur CP
    Indian J Med Res; 2007 Nov; 126(5):447-51. PubMed ID: 18160749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematological aspects of Indian kalaazar.
    Chatterjea JB; Sen Gupta PC
    J Indian Med Assoc; 1970 Jun; 54(12):541-52. PubMed ID: 5503461
    [No Abstract]   [Full Text] [Related]  

  • 7. Haematological investigations in visceral leishmaniasis.
    Kager PA; Rees PH
    Trop Geogr Med; 1986 Dec; 38(4):371-9. PubMed ID: 3810841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function studies in Indian kala-azar.
    Dube B; Arora A; Singh VP; Kumar K; Sundar S
    J Trop Med Hyg; 1995 Jun; 98(3):166-8. PubMed ID: 7783273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological findings in kala-azar, Iran.
    Behforouz NC; Amirhakimi GH; Rezai HR; Saberi MS
    Trop Geogr Med; 1983 Mar; 35(1):27-32. PubMed ID: 6612770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kala-azar elimination programme in India.
    Dhillon GP; Sharma SN; Nair B
    J Indian Med Assoc; 2008 Oct; 106(10):664, 666-8. PubMed ID: 19552101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1).
    Kumar V; Kesari S; Dinesh DS; Tiwari AK; Kumar AJ; Kumar R; Singh VP; Das P
    J Vector Borne Dis; 2009 Sep; 46(3):225-9. PubMed ID: 19724087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
    Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal periodicity of Leishmania amastigotes in peripheral blood of Indian Kala-azar patients.
    Saran R; Sharma MC; Gupta AK; Sinha SP; Kar SK
    Acta Trop; 1997 Dec; 68(3):357-60. PubMed ID: 9492920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A search for Leishmania in normal skin and blood of Kala-Azar patients from Bihar, India.
    Saran R; Gupta AK; Prasad LS
    J Commun Dis; 1988 Mar; 20(1):89-90. PubMed ID: 3230291
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematological and serological aspects of Mediterranean kala-azar in infancy and childhood.
    Li Volti S; Fischer A; Musumeci S
    Acta Trop; 1980 Dec; 37(4):351-65. PubMed ID: 6110325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.